Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
PBPH
56
HOLDINGS
20%
ALSO IN PPH
PPH
27
HOLDINGS
42%
ALSO IN PBPH
SECTOR DRIFT (PBPH minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBPH |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.5% | 21.7% | 15.5% |
|
MERCK & CO. INC. | 5.7% | 12.7% | 5.7% |
|
ABBVIE INC | 7.2% | 3.8% | 3.8% |
|
PFIZER INC | 3.5% | 5.2% | 3.5% |
|
JOHNSON & JOHNSON | 10.0% | 3.3% | 3.3% |
PBPH Overweight Relative to PPH
|
JOHNSON & JOHNSON | 6.7% |
 |
ASTRAZENECA PLC | 4.7% |
|
AMGEN INC | 4.3% |
 |
NOVARTIS AG | 4.2% |
|
GILEAD SCIENCES INC | 4.0% |
|
ABBVIE INC | 3.4% |
|
VERTEX PHARMACEUTICALS INC | 2.8% |
 |
NOVO NORDISK A/S-B | 2.6% |
|
GSK PLC | 2.0% |
 |
SANOFI-AVENTIS | 1.9% |
PBPH Underweight Relative to PPH
|
MERCK & CO. INC. | -7.0% |
|
ELI LILLY & CO | -6.2% |
|
NOVO-NORDISK A/S-SPONS ADR | -5.5% |
|
MCKESSON CORP | -4.8% |
 |
TEVA PHARMACEUTICAL-SP ADR | -4.5% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.5% |
|
CENCORA INC | -4.4% |
|
NOVARTIS AG-ADR | -3.6% |
|
ASTRAZENECA PLC-SPONS ADR | -3.6% |
|
SANOFI-AVENTIS-ADR | -3.2% |